ICICI Prudential Life Insurance Company Limited has announced its scheduled participation in the J.P. Morgan Asia Insurance Forum, filing the mandatory disclosure with stock exchanges on April 30, 2026. The investor meeting represents the company's ongoing engagement with the investment community through structured forums.

Meeting Details and Format

The company will participate in a group meeting format as part of the J.P. Morgan Asia Insurance Forum. The session has been scheduled for May 6, 2026, and will be conducted virtually through video conference technology.

Regulatory Compliance and Communication

The formal disclosure was addressed to both BSE Limited at Phiroze Jeejeebhoy Towers, Dalal Street, and National Stock Exchange of India Limited at Exchange Plaza, Bandra-Kurla Complex. The communication was filed under Regulation 30 and Regulation 46(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Company Secretary Priya Nair (ACS 17769) signed the digital communication on April 30, 2026, at 13:18:45 +05'30', emphasizing that no unpublished price sensitive information will be shared during the meeting. The company noted that the meeting schedule remains subject to change due to potential exigencies on the part of either the investor or the company.

Corporate Information

ICICI Prudential Life Insurance Company Limited operates from its offices at 1st and 2nd Floor, Cnergy IT Park, Appasaheb Marathe Marg, Prabhadevi, Mumbai - 400025. The company's registered office is located at ICICI PruLife Towers, 1089, Appasaheb Marathe Marg, Prabhadevi, Mumbai - 400025, with CIN: L66010MH2000PLC127837.

Additional details about the meeting can be accessed through the company's official website at iciciprulife.com. The company maintains transparency standards required for listed entities engaging with institutional investors and analysts through organized forums.

ICICI Prudential Life Insurance Company Limited has completed the allotment of equity shares under its Employee Stock Option Scheme, marking another step in its employee compensation strategy. The company informed stock exchanges about this corporate action through an official communication on April 28, 2026.

Share Allotment Details

The company has allotted equity shares to employees under its established stock option program. The allotment specifics are outlined in the following table:

Approval and Authorization

The allotment received approval from the Managing Director & CEO of the company on April 28, 2026. This approval was granted pursuant to the authority delegated by the Board of Directors at its meeting held on January 22, 2019. The delegation of authority allows the management to execute employee stock option allotments without requiring fresh board approval for each instance.

Share Rights and Status

The newly allotted equity shares carry equal rights and privileges as the existing equity shares of the company. The shares rank pari-passu with existing equity shares, ensuring that employees receiving these shares under the ESOP have the same voting rights, dividend entitlements, and other shareholder benefits as other equity shareholders.

Regulatory Compliance

The company has fulfilled its disclosure obligations by informing both the Bombay Stock Exchange (BSE) and the National Stock Exchange of India (NSE) about this allotment. The communication was signed by Company Secretary Priya Nair and includes all necessary details required under regulatory guidelines for such corporate actions.